Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
10/2007
10/04/2007US20070232665 Synthesis and regioselective substitution of 6-halo-and 6-alkoxy nicotine derivatives
10/04/2007US20070232664 Iron binding agents
10/04/2007US20070232663 Small molecule insulin mimetics absent quinones
10/04/2007US20070232662 Indol-2-One Derivatives for the Treatment of Central Nervous Disorders, Gastrointestinal Disorders and Cardiovascular Disorders
10/04/2007US20070232661 Hedgehog Pathway Antagonists
10/04/2007US20070232660 Therapeutic and delivery methods of prostaglandin ep4 agonists
10/04/2007US20070232659 Novel Alkyl Substituted Piperidine Derivatives as Monoamine Neurotransmitter Re-Uptake Inhibitors
10/04/2007US20070232658 Protein Kinase C Inhibitors for the Treatment of Autoimmune Diseases and of Transplant Rejiction
10/04/2007US20070232657 Novel compounds
10/04/2007US20070232656 Pharmaceutical Composition And Method For Treating Neurodegenerative Disorders
10/04/2007US20070232654 Novel Compounds and Compositions as Cathepsin Inhibitors
10/04/2007US20070232653 Process for the preparation of enantiomerically enriched cyclic beta-aryl or heteroaryl carbocyclic acids
10/04/2007US20070232652 Serotonin transporter (sert) inhibitors for the treatment of depression and anxiety
10/04/2007US20070232651 Novel anabaseine derivatives, pharmaceutical compositions and methods of use thereof
10/04/2007US20070232650 Malate salts, and polymorphs of (3S,5S)-7-[3-amino-5-methyl-piperidinyl]-1-cyclopropyl-1,4-dihydro-8-methoxy-4-oxo-3-quinolinecarboxylic acid
10/04/2007US20070232649 Heteroaryl Sulfones and Sulfonamides and Therapeutic Uses Thereof
10/04/2007US20070232648 Modulators of the glucocorticoid receptor and method
10/04/2007US20070232647 Use of Ppar Agonists to Treat Ruminants
10/04/2007US20070232646 Tropane prodrugs with central nervous system activity
10/04/2007US20070232645 Anti-viral compounds
10/04/2007US20070232644 Inhibitors of the Hiv Integrase Enzyme
10/04/2007US20070232643 Quinoline derivative, e.g. 2[4-(7-chloroquinolin-2-yloxy)phenoxy]propionic acid sodium salt; anticarcinogenic, antitumor agent; colon, breast, melanoma, pancreatic cancer or adenocarcinoma; melanoma, or leukemia; based on herbicides
10/04/2007US20070232642 2-amino-3,4-dihydro-quinoline derivatives useful as inhibitors of beta-secretase (bace)
10/04/2007US20070232641 exo-3-(3,4-Dichloro-phenoxy)-9-methyl-9-aza-bicyclo[3.3.1]nonane; central nervous system disorders
10/04/2007US20070232640 Antifungal and antiparasitic indoloquinoline derivates
10/04/2007US20070232639 Camptothecin Derivatives Conjugated in Position 20 with Integrin Antagonists
10/04/2007US20070232638 Opiopathies
10/04/2007US20070232637 Combinations Comprising Antimuscarinic Agents and Pde4 Inhibitors
10/04/2007US20070232636 schizophrenia, emesis, anxiety and depression, irritable bowel syndrome (IBS), circadian rhythm disturbances, pre-eclampsia, nociception, visceral and neuropathic pain, pancreatitis, neurogenic inflammation, asthma, COPD and micturition disorders such as urinary incontinence
10/04/2007US20070232635 Monocyclic and bicyclic himbacine derivatives useful as thrombin receptor antagonists
10/04/2007US20070232634 Tetrahydropyridines with central nervous system activity
10/04/2007US20070232633 Condensing (3-trifluoromethylsulfonyl) benzoyl chloride and 4-methyl-2-nitro-aniline; reducing nitro group with stannous chloride; condensing amino group with cyanamide; cyclocondensing guanidine group with 3-dimethylamino-1-pyridin-3-yl-propenone; antiproliferative agents
10/04/2007US20070232632 Sulfoximine-substituted pyrimidines, processes for production thereof and use thereof as drugs
10/04/2007US20070232631 1-[4-(5-Bromopyrimidin-2-ylsulfanyl)phenyl]-3-(2-nitrobenzoyl)-urea; antiproliferative, water soluble compound with high bioavailability
10/04/2007US20070232630 MACROCYCLE DERIVATIVES USEFUL AS INHIBITORS OF beta-SECRETASE (BACE)
10/04/2007US20070232629 Adhesive Patch
10/04/2007US20070232628 Calcium receptor antagonists; 2-(2-hydroxy-phenyl)-3-(4-isopropyl-phenyl)-5,6,7,8-tetrahydro-3H-quinazolin-4-one; bone disorders; hypoparathyroidism, osteosarcoma, periodontal disease, fracture healing, osteoarthritis, rheumatoid arthritis, Paget's disease, humoral hypercalcemia, osteoporosis
10/04/2007US20070232627 Anti-viral compounds
10/04/2007US20070232626 Purine Derivatives as A3 and A1 Adenosine Receptor Agonists
10/04/2007US20070232624 Use of paliperidone for the treatment of sleep disturbances and/or excessive daytime sleepiness in psychiatric patients
10/04/2007US20070232623 Pyrazolopyrimidine and Pyrazolotriazine Derivatives and Pharmaceutical Compositions Containing Them
10/04/2007US20070232622 Small molecule toll-like receptor (TLR) antagonists
10/04/2007US20070232621 Linear dicationic terphenyls and their aza analogues as antiparasitic agents
10/04/2007US20070232620 N-3-chlorobenzyl-3-amino-1H-indazole-5-carboxamide; 3-aminoindazoles; glucocorticoid-depedent kinase (SGK) inhibitors; SGK-induced diseases; diabetes, obesity, metabolic syndrome (dyslipidaemia), systemic and pulmonary hypertonia, cardiovascular diseases and renal diseases, fibrosis; inflammatory agents
10/04/2007US20070232619 Piperazine Derivatives of Dialkyl Oxindoles
10/04/2007US20070232618 Heterocyclyl-3-sulfonylindazoles as 5-hydroxytryptamine-6 ligands
10/04/2007US20070232617 Indole-type derivatives as inhibitors of p38 kinase
10/04/2007US20070232616 [5-(4,6-Dimethyl-1H-benzoimidazol-2-yl)-pyridin-2-yl]-methyl-[3-(1-methyl-piperidin-4-yl)-propyl]-amine; for diseases related to H4 receptor activity, including allergy, asthma, autoimmune diseases, and pruritus
10/04/2007US20070232615 Chemical Compounds
10/04/2007US20070232614 Therapeutic Agent for Nonviral Hepatitis
10/04/2007US20070232613 4-(1-Piperazinyl)-2(1H)-quinolone and 4-(1-piperazinyl)quinoline derivatives, e.g., 3-nitro- or 3-alkoxycarbonyl-1-methyl-4-[4-thiophene-2-carbonyl)-piperazine-1-yl]-1H-quinolin-2-one; antitumor and angiogenesis inhibitor, antiinflammatory, antidiabetic agent, autoimmune disorder
10/04/2007US20070232612 Octahydro-pyrrolo[3,4-b]pyrrole Derivatives
10/04/2007US20070232611 Amide Derivatives of 3-Phenyl-Dihydropyrimido[4,5-D]Pyrimidinones, Their Manufacture and Use as Pharmaceutical Agents
10/04/2007US20070232610 Novel compounds that are ERK inhibitors
10/04/2007US20070232609 Novel Antiparasitic Combination of Active Compounds
10/04/2007US20070232608 Prophylaxis of diabetes; (1SR,3RS)-3-{2-[(2S)-2-Cyanopyrrolidin-1-yl]-2-oxoethylamino}cyclopentane-1-carboxamide; non-insulin dependent diabetes mellitus, impaired glucose homeostasis, impaired glucose tolerance, infertility, polycystic ovary syndrome
10/04/2007US20070232607 Quinazoline Derivatives as Erbb Receptor Tyrosine kinases
10/04/2007US20070232606 Compounds and Compositions as Cathepsin S Inhibitors
10/04/2007US20070232605 Inhibitors of soluble adenylate cyclase
10/04/2007US20070232604 receptor kinase inhibitors such as 3-(2-{4-[3-(5-tert-Butyl-isoxazol-3-yl)-ureido]-phenyl}-benzo[d]imidazo[2,1-b]thiazol-7-yl)-N-(2-morpholin-4-yl-ethyl)-propionamide; flk inhibitors
10/04/2007US20070232603 Small-molecule modulators of TRP-P8 activity
10/04/2007US20070232602 Thiophene Derivatives, Their Manufacture and Use as Pharmaceutical Agents
10/04/2007US20070232601 Vla-4 Inhibitor
10/04/2007US20070232600 Anti-migraine treatments
10/04/2007US20070232599 Muscarinic Acetylcholine Receptor Antagonists
10/04/2007US20070232597 Compounds, Compositions, and Methods
10/04/2007US20070232596 10-(o-Hydroxyphenyl)--3a,4,9,10-tetrahydro-2-alkyl-2,9,10a-triazacyclopenty[b]fluorene-1,3-diones or the corresponding 2,10a-diaza-9 oxafluorenediones or 1,10a-diaza-9-thiafluorenediones; antiproliferative, apoptosis-inducing agents; treating color cancer
10/04/2007US20070232595 Method for accelerating cutaneous barrier recovery
10/04/2007US20070232594 Aromatic amide derivatives, medicinal compositions containing the same, medical uses of both
10/04/2007US20070232593 ANTIFUNGAL 4-SUBSTITUTED 5,6-DIHYDRO-4H-PYRROLO [1,2-a][1,4]BENZODIAZEPINES
10/04/2007US20070232592 Therapeutic Compositions Containing at Least one Pyrrolobenzodiazepine Derivative and Fludarabine
10/04/2007US20070232591 such as 1-(4-Cyclobutyl-piperazin-1-yl)-2-(6-methoxy-3,4-dihydro-1H-isoquinolin-2-yl)-ethanone, used for treating attention deficit disorder, epilepsy, headaches, sleep disorders, narcolepsy, rhinitis, motion sickness, Parkinson's disease, obesity, eating disorder or diabetes
10/04/2007US20070232590 3-Cylcoalkylbenzazepines as Histamine H3 Antagonists
10/04/2007US20070232589 Pharmaceutical Composition And Method For Treating Neurodegenerative Disorders
10/04/2007US20070232588 Anti-parasitic and/or anti-viral and/or anti-microbial compositions
10/04/2007US20070232587 4-Propionyl-(6-phenoxycarbonyl-6-azabicylo[3.2.2]non-3-ene; methyl-(2 alpha-phenyl-6-phenoxycarbonyl-6-azabicyclo[3.2.2]nona-3-ene)-4-carboxylate; bipolar disorders, depression, mood disorders, addictions, cognitive disorders, neurodegenerative diseases such as Alzheimer's disease, Parkinson's disease
10/04/2007US20070232586 Hydrazino-Substituted Heterocyclic Nitrile Compounds and Use Thereof
10/04/2007US20070232585 Sigma Receptor Inhibitors
10/04/2007US20070232584 Composition and Method for the Treatment of Tauopathies
10/04/2007US20070232583 Central nervous system disorders; metabotropic glutamate receptors (mGluR); 2-(4-Pyridin-3-yl-imidazol-1-yl)-4-trifluoromethyl-6-(4-trifluoromethyl-phenyl)-pyrimidine
10/04/2007US20070232582 4-substituted or unsubtituted-7-hydro-1,4-thiazepine-7-[bicyclic or tricyclic heteroaryl] substituted-3,6-dicarboxylic acid derivatives as beta-lactamase inhibitors
10/04/2007US20070232581 Alzheimer's disease; compounds inhibit the production of A beta -peptide; improved pharmacokinetics; N-((4-amino-3,5-dichlorobenzylamino)(amino)methylene)-3-(isobutoxyimino)-3-(4-methoxyphenyl)propanamide
10/04/2007US20070232580 Novel sterol/stanol nitroderivatives and use thereof in treating or preventing cardiovascular disease, its underlying conditions and other disorders
10/04/2007US20070232579 Nitrated Lipids and Methods of Making and Using Thereof
10/04/2007US20070232578 Crystalline forms of ciclesonide
10/04/2007US20070232577 Synthetic pentacyclic triterpenoids and derivatives of betulinic acid and betulin
10/04/2007US20070232576 Sulfated molecular umbrellas as anti-HIV and anti-HSV agents
10/04/2007US20070232575 Treatment of Pulmonary Artery Hypertension with Dhea, Dheas, Dhea Analogs, or Dhea Derivatives
10/04/2007US20070232574 2-Oxothiazolidine 4-Carboxylic acid compounds for promoting desquamation of the skin
10/04/2007US20070232573 Ethanoic acid derivatives as dipeptidyl peptidase inhibitors
10/04/2007US20070232572 Chemical derivatives as antitelomerase agents which bind specifically to the G-quadruplex DNA structures and their application as a specific anticancer agent
10/04/2007US20070232571 Novel Heteroaromatic Inhibitors of Fructose-1,6-Bisphosphatase
10/04/2007US20070232570 11-phosphorous steroid derivatives useful as progesterone receptor modulators
10/04/2007US20070232569 Treatments for cancer
10/04/2007US20070232568 Carbohydrate Composition and Its Use for the Preparation of a Medicament for Treating or Preventing Pulmonary Inflammation or Acute Respiration Distress Syndrome
10/04/2007US20070232567 Formulations Of Low Dose Non-Steroidal Anti-Inflammatory Drugs And Beta-Cyclodextrin
10/04/2007US20070232566 Formulations Of Low Dose Diclofenac And Beta-Cyclodextrin
10/04/2007US20070232565 Novel polysaccharides and oligosaccharides
10/04/2007US20070232564 Fish-Origin Chondroitin Sulfate/Dermatan Sulfate Hybrid Chain
10/04/2007US20070232563 Method for Enhancing Biological Activity and/or Expanding Suitable Region for Biological Activity of Living Body Contacting with Aqueous Environment
1 ... 3557 3558 3559 3560 3561 3562 3563 3564 3565 3566 3567 3568 3569 3570 3571 3572 3573 3574 3575 3576 3577 ... 7860